Healthcare Pharmaceuticals, Inc. (Healthcare)

Oncology Corporate Profile

HQ Location

Cambridge, MA

Company Description

HealthCare Pharmaceuticals, Inc. is developing novel, targeted drugs for the treatment of cancer. DKN-01, our clinical stage humanized monoclonal antibody, targets the Dickkopf-1 (DKK-1) protein. DKN-01 is presently being studied in Phase 1 clinical trials in tumors which have been linked to elevated circulating levels of DKK-1 or osteolytic bone disease, including non-small cell lung cancer, esophageal cancer and multiple myeloma.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
DKN-01DKK1 protein inhibitorMultiple MyelomaI
DKN-01DKK1 protein inhibitorNon Small Cell Lung Cancer (NSCLC)I

View additional information on product candidates here »


Recent News Headlines

There are no news items to display